Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
โ
3.72%
Grew
โ
โ
Shrank
โ
1 Year
Scoreโ
Net Growth3.72%
Net TrendGrew
Net Income Consistencyโ
Rev Growthโ
Rev TrendShrank
Revenue Consistencyโ
5 Years
โ
-21.36%
80%
โ
โ
Never
โ
5 Years
Scoreโ
Net Growth-21.36%
Net Trend80%
Net Income Consistencyโ
Rev Growthโ
Rev TrendNever
Revenue Consistencyโ
Explore the 2021 public Archive ranking โ
Where Climb Bio Inc has ranked, year by year
Measure
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CLYM does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-11-13 | $ 10.36 | โ |
1 Year2025-11-13 | $ 1.87 | 454.01% |
5 Years2021-11-12 | $ 17.94 | -42.25% |
All Time2021-08-10 | $ 15.90 | -34.84% |
| Period | Last Price2026-11-13 | 1 Year2025-11-13 | 5 Years2021-11-12 | All Time2021-08-10 |
|---|---|---|---|---|
| Price | $ 10.36 | $ 1.87 | $ 17.94 | $ 15.90 |
| Return | โ | 454.01% | -42.25% | -34.84% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 0.00 | -$ 57M | $ 183M |
| 2025 | $ 0.00 | -$ 59M | $ 101M |
| 2024 | $ 0.00 | -$ 73M | $ 150M |
| 2023 | $ 0.00 | -$ 35M | $ 106M |
| 2022 | $ 0.00 | -$ 45M | $ 123M |
| IPO2021 | $ 0.00 | -$ 47M | $ 136M |

Climb Bio Inc fundamental performance
Across Climb Bio Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 47M to -$ 59M. Revenue increased in 0% of the years measured; net income in 80%.
Membership
Explore CLYM with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,195 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio




